Cite
HARVARD Citation
Higgs, E. et al. (2021). PREVAIL IV: A Randomized, Double-Blind, 2-Phase, Phase 2 Trial of Remdesivir vs Placebo for Reduction of Ebola Virus RNA in the Semen of Male Survivors. Clinical infectious diseases. pp. 1849-1856. [Online].